QOL assessments from family caregivers agreed more closely with patients than did those from nurses using EQ-5D evaluations for patients with clear cognition, but either proxy was acceptable for rating PMV patients with poor cognition.
With the improvement of PMV technology in the early 2000s, the establishment of ISRIRC seems to be associated with an improved survival rate for subjects under PMV.
Theses results of poor prognosis would provide stakeholders evidence for communication to facilitate clinical decisions. The estimation may be used in future studies to facilitate the cost-effectiveness and reduction of the health gap.
Objectives: Transcerebellar diameter (TCD) and cisterna magna (CM) depth are standard measurement used to evaluate posterior fossa abnormality. However, sonographic acquisition of an axial plane is subjective depending on the degree of tilting. Thus, the objective of this study was to compare transcerebellar diameter and cisterna magna depth measurements made manually in 2D versus using 3D automated TCD program. Methods: Total of 20 singleton pregnancies beween 20+0 and 24+0 weeks of gestation was included. Multifetal pregnancy, oligohyramnios, fetus with central nervous system anomaly were excluded. Transcerebellar axial plane was obtained to measure TCD and CM manually using 2-6-MHz transabdominal transducer (SamsungMedison Co, Ltd, Seoul, Korea). The process was repeated twice. 3D ultrasound volume of the fetal head was obtained transabdominally with Accuvix V20 Prestige (SamsungMedison Co, Ltd, Seoul, Korea) using 4-8-MHz volume transducer. Volume sweep was initiated in transcerebellar axial plane for measuring biparietal diameter with sweep angle set at 60 degrees. The volume data were subjected to off-line auto TCD program that automatically manipulated the volume to produce transcerebellar axial plane and automatically places calipers for TCD and CM depth measurement. The program was applied twice for each case. Results: The median gestational age at the scanning was 21 weeks and 3 days. In all cases, TCD and CM depth were successfully obtained by 2D manual and 3D automated methods. Median TCD and CM depth were 21.10 ± 0.82 and 4.70 ± 0.57 mm and 19.56 ± 1.16 and 4.37 ± 0.53 mm, respectively, using 2D manual and 3D automated methods. No significant differences in the measurements among 2D and 3D automated method was observed. The mean difference of intraobserver variability for TCD and CM depth were non-significant.
Conclusions:The automated TCD program, a novel technique for automated axial plane acquisition and TCD and CM depth measurement using 3D volume data, was feasible and highly reproducible. Fetus in Fitu (FIF) is a rare abnormality secondary to the abnormal embryogenesis in a diamniotic, monochorionic pregnancy. The presence of a vertebral axis in a fetiform mass is considered pathognomic of FIF. It must be diffrentiated from a retroperitoneal mature teratoma (RMT). The incidence of FIF is 1:500,000 live births and prenatal diagnosis is possible in 15% of cases only (as in our case) We present a case of young primi with 6 mnths of pregnancy for routine antenatal scan. A large well-defined, encapsulated hypoechoic lesion containg a well-defined bone was noted in the retroperitoneum adjacent to the lower pole of right kidney. The tentative diagnosis of ''Retroperitoneal Teratoma'' was put. Antenatal MRI revealed the presence of vertebral axis and the likelihood of FIF.
P11.09 Prenatal diagnosis of fetus in fetus (FIF) with MRI and biopsy confirmationThe newborn deilvered at our institute was operated and histopathological examination confirmed the diagnosis of FIF. Hence antenatal MRI is an import...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.